Published in Breast Cancer Res on September 04, 2015
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc (2012) 35.75
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res (2009) 23.27
FIMO: scanning for occurrences of a given motif. Bioinformatics (2011) 8.89
UniPROBE: an online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res (2008) 6.83
JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res (2013) 6.12
Modulating Hox gene functions during animal body patterning. Nat Rev Genet (2005) 5.10
MultiPipMaker and supporting tools: Alignments and analysis of multiple genomic DNA sequences. Nucleic Acids Res (2003) 4.97
Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet (2006) 4.75
Sources of estrogen and their importance. J Steroid Biochem Mol Biol (2003) 2.54
Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell (2011) 2.23
The pathophysiology of HOX genes and their role in cancer. J Pathol (2005) 2.18
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer. Clin Cancer Res (2009) 2.10
The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell (2009) 2.07
Endocrine regulation of HOX genes. Endocr Rev (2006) 2.04
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators. Cancer Chemother Pharmacol (2005) 2.01
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res (2009) 1.98
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J (2011) 1.72
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev (2003) 1.60
Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol (2001) 1.53
Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer (2003) 1.53
Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol (2008) 1.41
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol (2008) 1.36
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat (2009) 1.35
Regeneration, repair and remembering identity: the three Rs of Hox gene expression. Trends Cell Biol (2009) 1.35
Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol (2007) 1.25
Local estrogen biosynthesis in males and females. Endocr Relat Cancer (1999) 1.24
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res (2014) 1.23
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome. Breast Cancer Res (2013) 1.22
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer. FASEB J (2007) 1.19
Defining transcribed regions using RNA-seq. Nat Protoc (2010) 1.17
Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. Carcinogenesis (2008) 1.15
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer (2013) 1.11
Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. Adv Exp Med Biol (2008) 1.01
Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]. Cancer Res (2010) 1.00
Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion. Mol Cancer (2010) 1.00
GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A (2013) 0.99
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer. Sci Transl Med (2014) 0.94
Breast cancer. Breast cancer: a world of differences. Science (2014) 0.90
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. Breast Cancer Res Treat (2008) 0.90
Parathyroid tumor development involves deregulation of homeobox genes. Endocr Relat Cancer (2008) 0.87
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol Cancer Res (2010) 0.87
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells. Clin Cancer Res (2012) 0.86
Estrogen represses gene expression through reconfiguring chromatin structures. Nucleic Acids Res (2013) 0.85
Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate (2007) 0.85
Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer. Br J Surg (2014) 0.83
Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer. Cancer Med (2013) 0.82
Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells. J Cell Biochem (2008) 0.82
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer. Breast Cancer Res (2014) 0.79
Prosaposin, a regulator of estrogen receptor alpha, promotes breast cancer growth. Cancer Sci (2012) 0.78
Hormone resistance. Cancer Treat Res (2009) 0.76